[A4M CERTIFICATION STUDY GUIDE | ANTI-AGING & FUNCTIONAL MEDICINE REVIEW | BOARD EXAM
PREPARATION] QUESTIONS AND ANSWERS ALREADY GRADED A+| 100% VERIFIED SOLUTIONS………...
Core Domains:
Hormonal Assessment and Replacement Therapy
Nutritional Biochemistry and Supplementation
Genetics, Epigenetics, and Personalized Medicine
Metabolic Syndrome and Cardiovascular Risk Management
Detoxification Pathways and Environmental Medicine
Immunosenescence and Chronic Inflammation
Neurocognitive Health and Stress Management
Regenerative Medicine and Aesthetic Applications
Ethical, Legal, and Practice Management in Functional Medicine
Introduction
This comprehensive examination is designed to rigorously assess the candidate's mastery of the core principles and
clinical applications of anti-aging and functional medicine. It evaluates the integration of foundational scientific
theory with advanced clinical knowledge, emphasizing a systems-based approach to patient care. The exam
utilizes a multiple-choice format to test the candidate's ability to analyze complex patient scenarios, identify
underlying pathophysiological mechanisms, and formulate effective, evidence-based treatment strategies.
Questions are structured to reflect real-world clinical decision-making, requiring the candidate to prioritize
interventions, interpret advanced diagnostic testing, and apply the principles of personalized, patient-centered
,care. Mastery of these competencies is essential for board certification and the provision of high-quality, integrative
healthcare.
SECTION ONE: QUESTIONS 1–100
1. A 55-year-old male patient presents with complaints of fatigue, decreased libido, and mild erectile
dysfunction. His morning total testosterone level is 280 ng/dL (normal: 300-1000 ng/dL). Which of the following
is the most appropriate next step in the evaluation of this patient?
A. Immediately initiate testosterone replacement therapy (TRT).
B. Check a serum estradiol level and a prostate-specific antigen (PSA).
C. Repeat the total testosterone level in the afternoon.
D. Refer the patient to a urologist for a prostate biopsy.
🟢B
🔴 RATIONALE: Before initiating TRT, it is essential to evaluate the patient's estradiol (E2) level to assess for
potential aromatization of testosterone and monitor PSA to rule out prostate cancer. TRT is contraindicated in
patients with untreated prostate cancer. A single low total testosterone level should be confirmed with a repeat
morning level before treatment (A is premature). Testosterone levels are highest in the morning, so repeating in
the afternoon (C) would be inappropriate. A prostate biopsy (D) is not indicated without further evaluation (e.g.,
elevated PSA or abnormal DRE).
2. In the context of mitochondrial health and aging, which of the following is considered a primary driver of
cellular senescence?
,A. Increased telomerase activity
B. Decreased reactive oxygen species (ROS) production
C. Cumulative oxidative damage to mitochondrial DNA (mtDNA)
D. Enhanced autophagic clearance of damaged organelles
🟢C
🔴 RATIONALE: Mitochondria are a major source of ROS, and mtDNA is more susceptible to damage due to its
lack of protective histones. Cumulative oxidative damage to mtDNA leads to mitochondrial dysfunction,
reduced ATP production, and cellular senescence, contributing to the aging process. Increased telomerase
activity (A) is associated with cellular immortality and is not a driver of senescence. Decreased ROS (B) would be
protective. Enhanced autophagy (D) is a mechanism to clear damaged mitochondria and is protective against
senescence.
3. A 62-year-old female patient with a history of mild cognitive impairment is interested in neuroprotective
supplementation. Which of the following combinations has the strongest evidence base for supporting
cognitive function in this population?
A. Vitamin C and Vitamin E
B. Omega-3 fatty acids (EPA/DHA) and Coenzyme Q10
C. Ginkgo Biloba and St. John's Wort
D. Resveratrol and L-Arginine
🟢B
🔴 RATIONALE: Omega-3 fatty acids (EPA and DHA) are essential for brain structure and function and have
shown benefits in cognitive aging. Coenzyme Q10 is a mitochondrial cofactor that may support neuronal
, energy metabolism. This combination addresses both structural and energetic aspects of brain health. Vitamin C
and E (A) are antioxidants but have limited evidence for cognitive improvement. Ginkgo Biloba (C) has mixed
evidence, and St. John's Wort is for mood disorders. Resveratrol and L-Arginine (D) are more focused on
cardiovascular health.
4. A patient's genomic testing reveals a heterozygous mutation in the MTHFR C677T gene. What is the primary
clinical implication of this finding?
A. Increased risk for deep vein thrombosis
B. Impaired conversion of homocysteine to methionine
C. Reduced ability to absorb vitamin B12
D. Increased requirement for dietary folate
🟢B
🔴 RATIONALE: The MTHFR enzyme is responsible for converting 5,10-methylenetetrahydrofolate to 5-
methyltetrahydrofolate, which is the active form of folate needed for the remethylation of homocysteine to
methionine. A C677T mutation reduces the activity of this enzyme, leading to elevated homocysteine levels. The
primary implication is an increased need for bioavailable, methylated forms of folate (like L-5-
methyltetrahydrofolate). While it can be a risk factor for thrombosis (A), it is not the primary implication. It does
not affect B12 absorption (C). The increased requirement is for bioactive folate, not dietary folate (D).
5. A patient presents with symptoms of fatigue, weight gain, and cold intolerance. Lab results show a TSH of 6.5
mIU/L (normal: 0.4-4.0 mIU/L) and a free T4 of 0.7 ng/dL (normal: 0.8-1.8 ng/dL). The patient has a known
diagnosis of Hashimoto's thyroiditis and is already on levothyroxine 50 mcg daily. Which of the following is the
most appropriate next step?
PREPARATION] QUESTIONS AND ANSWERS ALREADY GRADED A+| 100% VERIFIED SOLUTIONS………...
Core Domains:
Hormonal Assessment and Replacement Therapy
Nutritional Biochemistry and Supplementation
Genetics, Epigenetics, and Personalized Medicine
Metabolic Syndrome and Cardiovascular Risk Management
Detoxification Pathways and Environmental Medicine
Immunosenescence and Chronic Inflammation
Neurocognitive Health and Stress Management
Regenerative Medicine and Aesthetic Applications
Ethical, Legal, and Practice Management in Functional Medicine
Introduction
This comprehensive examination is designed to rigorously assess the candidate's mastery of the core principles and
clinical applications of anti-aging and functional medicine. It evaluates the integration of foundational scientific
theory with advanced clinical knowledge, emphasizing a systems-based approach to patient care. The exam
utilizes a multiple-choice format to test the candidate's ability to analyze complex patient scenarios, identify
underlying pathophysiological mechanisms, and formulate effective, evidence-based treatment strategies.
Questions are structured to reflect real-world clinical decision-making, requiring the candidate to prioritize
interventions, interpret advanced diagnostic testing, and apply the principles of personalized, patient-centered
,care. Mastery of these competencies is essential for board certification and the provision of high-quality, integrative
healthcare.
SECTION ONE: QUESTIONS 1–100
1. A 55-year-old male patient presents with complaints of fatigue, decreased libido, and mild erectile
dysfunction. His morning total testosterone level is 280 ng/dL (normal: 300-1000 ng/dL). Which of the following
is the most appropriate next step in the evaluation of this patient?
A. Immediately initiate testosterone replacement therapy (TRT).
B. Check a serum estradiol level and a prostate-specific antigen (PSA).
C. Repeat the total testosterone level in the afternoon.
D. Refer the patient to a urologist for a prostate biopsy.
🟢B
🔴 RATIONALE: Before initiating TRT, it is essential to evaluate the patient's estradiol (E2) level to assess for
potential aromatization of testosterone and monitor PSA to rule out prostate cancer. TRT is contraindicated in
patients with untreated prostate cancer. A single low total testosterone level should be confirmed with a repeat
morning level before treatment (A is premature). Testosterone levels are highest in the morning, so repeating in
the afternoon (C) would be inappropriate. A prostate biopsy (D) is not indicated without further evaluation (e.g.,
elevated PSA or abnormal DRE).
2. In the context of mitochondrial health and aging, which of the following is considered a primary driver of
cellular senescence?
,A. Increased telomerase activity
B. Decreased reactive oxygen species (ROS) production
C. Cumulative oxidative damage to mitochondrial DNA (mtDNA)
D. Enhanced autophagic clearance of damaged organelles
🟢C
🔴 RATIONALE: Mitochondria are a major source of ROS, and mtDNA is more susceptible to damage due to its
lack of protective histones. Cumulative oxidative damage to mtDNA leads to mitochondrial dysfunction,
reduced ATP production, and cellular senescence, contributing to the aging process. Increased telomerase
activity (A) is associated with cellular immortality and is not a driver of senescence. Decreased ROS (B) would be
protective. Enhanced autophagy (D) is a mechanism to clear damaged mitochondria and is protective against
senescence.
3. A 62-year-old female patient with a history of mild cognitive impairment is interested in neuroprotective
supplementation. Which of the following combinations has the strongest evidence base for supporting
cognitive function in this population?
A. Vitamin C and Vitamin E
B. Omega-3 fatty acids (EPA/DHA) and Coenzyme Q10
C. Ginkgo Biloba and St. John's Wort
D. Resveratrol and L-Arginine
🟢B
🔴 RATIONALE: Omega-3 fatty acids (EPA and DHA) are essential for brain structure and function and have
shown benefits in cognitive aging. Coenzyme Q10 is a mitochondrial cofactor that may support neuronal
, energy metabolism. This combination addresses both structural and energetic aspects of brain health. Vitamin C
and E (A) are antioxidants but have limited evidence for cognitive improvement. Ginkgo Biloba (C) has mixed
evidence, and St. John's Wort is for mood disorders. Resveratrol and L-Arginine (D) are more focused on
cardiovascular health.
4. A patient's genomic testing reveals a heterozygous mutation in the MTHFR C677T gene. What is the primary
clinical implication of this finding?
A. Increased risk for deep vein thrombosis
B. Impaired conversion of homocysteine to methionine
C. Reduced ability to absorb vitamin B12
D. Increased requirement for dietary folate
🟢B
🔴 RATIONALE: The MTHFR enzyme is responsible for converting 5,10-methylenetetrahydrofolate to 5-
methyltetrahydrofolate, which is the active form of folate needed for the remethylation of homocysteine to
methionine. A C677T mutation reduces the activity of this enzyme, leading to elevated homocysteine levels. The
primary implication is an increased need for bioavailable, methylated forms of folate (like L-5-
methyltetrahydrofolate). While it can be a risk factor for thrombosis (A), it is not the primary implication. It does
not affect B12 absorption (C). The increased requirement is for bioactive folate, not dietary folate (D).
5. A patient presents with symptoms of fatigue, weight gain, and cold intolerance. Lab results show a TSH of 6.5
mIU/L (normal: 0.4-4.0 mIU/L) and a free T4 of 0.7 ng/dL (normal: 0.8-1.8 ng/dL). The patient has a known
diagnosis of Hashimoto's thyroiditis and is already on levothyroxine 50 mcg daily. Which of the following is the
most appropriate next step?
